Lansoprazole is associated with worsening asthma control in children with the CYP2C19 poor metabolizer phenotype

Jason E. Lang, Janet T. Holbrook, Edward B. Mougey, Christine Y. Wei, Robert A. Wise, W. Gerald Teague, John J. Lima

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'Lansoprazole is associated with worsening asthma control in children with the CYP2C19 poor metabolizer phenotype'. Together they form a unique fingerprint.

Medicine & Life Sciences